Caxton team to Valence

The founders of Caxton Advantage Venture Partners are leaving to start a new firm, Valence Life Sciences.

Rachel Leheny and Eric Roberts started Caxton Advantage in 2006 as part of hedge fund Caxton Associates. At the new firm, their investment strategy will remain focused on private and public micro-cap biotechs with late-stage clinical data...